| Q39958680 | Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin |
| Q28476078 | Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin |
| Q37376668 | Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1 |
| Q39959876 | Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells |
| Q36350221 | Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA |
| Q36637900 | Current insights into the regulation of programmed cell death by NF-kappaB. |
| Q37649660 | Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer |
| Q33864180 | Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols |
| Q34787556 | Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells |
| Q53346181 | Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. |
| Q90638896 | Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression |
| Q36561723 | Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer |
| Q36901888 | Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy |
| Q28291669 | Good cop, bad cop: the different faces of NF-kappaB |
| Q28240447 | Histone deacetylases and cancer |
| Q35832054 | Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response |
| Q28485861 | Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1 |
| Q55265367 | Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles. |
| Q33976185 | Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation |
| Q30541124 | Interaction and antagonistic roles of NF-κB and Hes6 in the regulation of cortical neurogenesis |
| Q47777378 | Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway |
| Q37609283 | MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. |
| Q46304110 | Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts |
| Q36804306 | Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful? |
| Q28297985 | NF-kappaB and IKK as therapeutic targets in cancer |
| Q28477156 | NF-κB potentiates caspase independent hydrogen peroxide induced cell death |
| Q57306207 | NQO1 expression correlates inversely with NFκB activation in human breast cancer |
| Q42167968 | Noncanonical NF-κB mediates the Suppressive Effect of Neutrophil Elastase on IL-8/CXCL8 by Inducing NKRF in Human Airway Smooth Muscle |
| Q36637905 | Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression |
| Q58587674 | Nuclear factor-kappaB regulates multiple steps of gliogenesis in the developing murine cerebral cortex |
| Q39067763 | Nucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin |
| Q42632400 | Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. |
| Q37995693 | Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer |
| Q42483466 | S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. |
| Q28291658 | Signals from within: the DNA-damage-induced NF-kappaB response |
| Q34704519 | SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma |
| Q37518681 | Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines |
| Q38267049 | Targeting the NFκB signaling pathways for breast cancer prevention and therapy. |
| Q37976939 | The diverse and complex roles of NF-κB subunits in cancer |
| Q47813995 | The nuclear factor-kappa B pathway and response to treatment in breast cancer |
| Q37534942 | Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism |
| Q39921861 | Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions |
| Q35619335 | p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage |
| Q40105870 | p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress |